Long-term clinical outcomes of intravascular brachytherapy for multilayer drug-eluting in-stent restenosis

Multilayer DES-ISR is associated with a high rate of adverse outcomes at 3-year follow-up. Treatment with IVBT was associated with a lower rate of MACE compared to treatment with a non-IVBT strategy at long-term follow-up.